Genetic variants in MTNR1B affecting insulin secretion

References

• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
   PubMed Web of Science ®Google Scholar
• Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 2003;46:3–19.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992; 15:318–68.
   PubMed Web of Science ®Google Scholar
• Lieberman LS. Dietary, evolutionary, and modernizing influences on the prevalence of type 2 diabetes. Annu Rev Nutr. 2003;23:345–77.
   PubMed Web of Science ®Google Scholar
• Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, . A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881–5.
   PubMed Web of Science ®Google Scholar
• ; Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical ResearchSaxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, . Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331–6.
   PubMed Web of Science ®Google Scholar
• Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, . Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316:1336–41.
   PubMed Web of Science ®Google Scholar
• Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, . A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–5.
   PubMed Web of Science ®Google Scholar
• Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, . A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39:770–5.
   PubMed Web of Science ®Google Scholar
• Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, . A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–94.
   PubMed Web of Science ®Google Scholar
• Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, . Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet. 2007;39:977–83.
   PubMed Web of Science ®Google Scholar
• Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham SL, Daly A, . Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet. 2007;39:951–3.
   PubMed Web of Science ®Google Scholar
• Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, . Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40:638–45.
   PubMed Web of Science ®Google Scholar
• Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, Andersen G, . SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet. 2008;40:1098–102.
   PubMed Web of Science ®Google Scholar
• Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, . Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet. 2008;40:1092–7.
   PubMed Web of Science ®Google Scholar
• Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, . Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009;41:77–81.
   PubMed Web of Science ®Google Scholar
• Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, Cavalcanti-Proença C, . Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet. 2009;41:1110–5.
   PubMed Web of Science ®Google Scholar
• Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, . New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42:105–16.
   PubMed Web of Science ®Google Scholar
• Qi L, Cornelis MC, Kraft P, Stanya KJ, Linda Kao WH, Pankow JS, . Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet. 2010;19:2706–15.
   PubMed Web of Science ®Google Scholar
• Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res. 2008;44:26–40.
   PubMed Web of Science ®Google Scholar
• Boden G, Ruiz J, Urbain JL, Chen X. Evidence for a circadian rhythm of insulin secretion. Am J Physiol. 1996; 271:E246–52.
   PubMed Web of Science ®Google Scholar
• Laposky AD, Bass J, Kohsaka A, Turek FW. Sleep and circadian rhythms: key components in the regulation of energy metabolism. FEBS Lett. 2008;582:142–51.
   PubMed Web of Science ®Google Scholar
• Hampton SM, Morgan LM, Lawrence N, Anastasiadou T, Norris F, Deacon S, . Postprandial hormone and metabolic responses in simulated shift work. J Endocrinol. 1996;151:259–67.
   PubMed Web of Science ®Google Scholar
• Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A. 2009;106:4453–8.
   PubMed Web of Science ®Google Scholar
• Staiger H, Machicao F, Schafer SA, Kirchhoff K, Kantartzis K, Guthoff M, . Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS One. 2008;3:e3962.
   PubMed Web of Science ®Google Scholar
• Lyssenko V, Nagorny CL, Erdos MR, Wierup N, Jonsson A, Spégel P, . Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet. 2009;41:82–8.
   PubMed Web of Science ®Google Scholar
• Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparsø T, Holmkvist J, Marchand M, . A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet. 2009;41:89–94.
   PubMed Web of Science ®Google Scholar
• Ronn T, Wen J, Yang Z, Lu B, Du Y, Groop L, . A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia. 2009;52:830–3.
   PubMed Web of Science ®Google Scholar
• Sparso T, Bonnefond A, Andersson E, Bouatia-Naji N, Holmkvist J, Wegner L, . G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Diabetes. 2009;58:1450–6.
   PubMed Web of Science ®Google Scholar
• Langenberg C, Pascoe L, Mari A, Tura A, Laakso M, Frayling TM, . Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia. 2009; 52:1537–42.
   PubMed Web of Science ®Google Scholar
• Reiling E, van't Riet E, Groenewoud MJ, Welschen LM, van Hove EC, Nijpels G, . Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Diabetologia. 2009;52:1866–70.
   PubMed Web of Science ®Google Scholar
• Chambers JC, Zhang W, Zabaneh D, Sehmi J, Jain P, McCarthy MI, . Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes. 2009;58:2703–8.
   PubMed Web of Science ®Google Scholar
• Kelliny C, Ekelund U, Andersen LB, Brage S, Loos RJ, Wareham NJ, . Common genetic determinants of glucose homeostasis in healthy children: the European Youth Heart Study. Diabetes. 2009;58:2939–45.
   PubMed Web of Science ®Google Scholar
• Takeuchi F, Katsuya T, Chakrewarthy S, Yamamoto K, Fujioka A, Serizawa M, . Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia. 2010;53:299–308.
   PubMed Web of Science ®Google Scholar
• Andersson EA, Holst B, Sparso T, Grarup N, Banasik K, Holmkvist J, . The MTNR1B G24E variant associates with BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans. Diabetes. 2010;59: 1539–48.
   PubMed Web of Science ®Google Scholar
• Simonis-Bik AM, Nijpels G, van Haeften TW, Houwing-Duistermaat JJ, Boomsma DI, Reiling E, . Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes. 2010;59:293–301.
   PubMed Web of Science ®Google Scholar
• Stancakova A, Kuulasmaa T, Paananen J, Jackson AU, Bonnycastle LL, Collins FS, . Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes. 2009;58:2129–36.
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Langenberg C, Hivert MF, Prokopenko I, Lyssenko V, Dupuis J, . Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans. Diabetes. 2010;59:1266–75.
   PubMed Web of Science ®Google Scholar
• 't Hart LM, Simonis-Bik AM, Nijpels G, van Haeften TW, Schäfer SA, Houwing-Duistermaat JJ, . Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clamps. Diabetes. 2010;59:287–92.
   PubMed Web of Science ®Google Scholar
• Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A. 1995;92:8734–8.
   PubMed Web of Science ®Google Scholar
• Reppert SM, Weaver DR, Cassone VM, Godson C, Kolakowski LF Jr. Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron. 1995;15:1003–15.
   PubMed Web of Science ®Google Scholar
• von Gall C, Stehle JH, Weaver DR. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res. 2002;309:151–62.
   PubMed Web of Science ®Google Scholar
• Peschke E, Fauteck JD, Musshoff U, Schmidt F, Beckmann A, Peschke D. Evidence for a melatonin receptor within pancreatic islets of neonate rats: functional, autoradiographic, and molecular investigations. J Pineal Res. 2000;28:156–64.
   PubMed Web of Science ®Google Scholar
• Peschke E, Muhlbauer E, Musshoff U, Csernus VJ, Chankiewitz E, Peschke D. Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res. 2002;33:63–71.
   PubMed Web of Science ®Google Scholar
• Kemp DM, Ubeda M, Habener JF. Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol. 2002;191:157–66.
   PubMed Web of Science ®Google Scholar
• Muhlbauer E, Peschke E. Evidence for the expression of both the MT1- and in addition, the MT2-melatonin receptor, in the rat pancreas, islet and beta-cell. J Pineal Res. 2007;42:105–6.
   PubMed Web of Science ®Google Scholar
• Ramracheya RD, Muller DS, Squires PE, Brereton H, Sugden D, Huang GC, . Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res. 2008;44:273–9.
   PubMed Web of Science ®Google Scholar
• Peschke E, Peschke D, Hammer T, Csernus V. Influence of melatonin and serotonin on glucose-stimulated insulin release from perifused rat pancreatic islets in vitro. J Pineal Res. 1997;23:156–63.
   PubMed Web of Science ®Google Scholar
• Picinato MC, Haber EP, Cipolla-Neto J, Curi R, Oliveira Carvalho CR, Carpinelli AR. Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets. J Pineal Res. 2002;33:156–60.
   PubMed Web of Science ®Google Scholar
• Frankel BJ, Strandberg MJ. Insulin release from isolated mouse islets in vitro: no effect of physiological levels of melatonin or arginine vasotocin. J Pineal Res. 1991;11:145–8.
   PubMed Web of Science ®Google Scholar
• Nishida S. Metabolic effects of melatonin on oxidative stress and diabetes mellitus. Endocrine. 2005;27:131–6.
   PubMed Web of Science ®Google Scholar
• Gorray KC, Quay WB, Ewart RB. Effects of pinealectomy and pineal incubation medium and sonicates on insulin release by isolated pancreatic islets in vitro. Horm Metab Res. 1979;11:432–6.
   PubMed Web of Science ®Google Scholar
• Rasmussen DD, Boldt BM, Wilkinson CW, Yellon SM, Matsumoto AM. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology. 1999;140:1009–12.
   PubMed Web of Science ®Google Scholar
• Muhlbauer E, Gross E, Labucay K, Wolgast S, Peschke E. Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose. Eur J Pharmacol. 2009;606:61–71.
   PubMed Web of Science ®Google Scholar
• Peschke E, Stumpf I, Bazwinsky I, Litvak L, Dralle H, Muhlbauer E. Melatonin and type 2 diabetes—a possible link? J Pineal Res. 2007;42:350–8.
   PubMed Web of Science ®Google Scholar
• Peschke E, Bach AG, Muhlbauer E. Parallel signaling pathways of melatonin in the pancreatic beta-cell. J Pineal Res. 2006;40:184–91.
   PubMed Web of Science ®Google Scholar
• Regard JB, Kataoka H, Cano DA, Camerer E, Yin L, Zheng YW, . Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest. 2007;117:4034–43.
   PubMed Web of Science ®Google Scholar
• Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci. 2004;27:107–44.
   PubMed Web of Science ®Google Scholar
• Petit L, Lacroix I, de Coppet P, Strosberg AD, Jockers R. Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3′-5′-monophosphate pathway. Biochem Pharmacol. 1999;58:633–9.
   PubMed Web of Science ®Google Scholar
• Bach AG, Wolgast S, Muhlbauer E, Peschke E. Melatonin stimulates inositol-1,4,5-trisphosphate and Ca2+ release from INS1 insulinoma cells. J Pineal Res. 2005;39:316–23.
   PubMed Web of Science ®Google Scholar
• Sallinen P, Saarela S, Ilves M, Vakkuri O, Leppaluoto J. The expression of MT1 and MT2 melatonin receptor mRNA in several rat tissues. Life Sci. 2005;76:1123–34.
   PubMed Web of Science ®Google Scholar
• Sanchez-Hidalgo M, Guerrero Montavez JM, Carrascosa-Salmoral MP, Naranjo Gutierrez MC, Lardone PJ, de la Lastra Romero CA. Decreased MT1 and MT2 melatonin receptor expression in extrapineal tissues of the rat during physiological aging. J Pineal Res. 2009;46:29–35.
   PubMed Web of Science ®Google Scholar
• Brydon L, Petit L, Delagrange P, Strosberg AD, Jockers R. Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology. 2001;142: 4264–71.
   PubMed Web of Science ®Google Scholar
• Ha E, Yim SV, Chung JH, Yoon KS, Kang I, Cho YH, . Melatonin stimulates glucose transport via insulin receptor substrate-1/phosphatidylinositol 3-kinase pathway in C2C12 murine skeletal muscle cells. J Pineal Res. 2006;41:67–72.
   PubMed Web of Science ®Google Scholar
• Contreras-Alcantara S, Baba K, Tosini G. Removal of melatonin receptor type 1 induces insulin resistance in the mouse. Obesity (Silver Spring). 2010 Feb 18 (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Anhe GF, Caperuto LC, Pereira-Da-Silva M, Souza LC, Hirata AE, Velloso LA, . In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus. J Neurochem. 2004;90:559–66.
   PubMed Web of Science ®Google Scholar
• Shieh JM, Wu HT, Cheng KC, Cheng JT. Melatonin ameliorates high fat diet-induced diabetes and stimulates glycogen synthesis via a PKCzeta-Akt-GSK3beta pathway in hepatic cells. J Pineal Res. 2009;47:339–44.
   PubMed Web of Science ®Google Scholar
• Stumpf I, Muhlbauer E, Peschke E. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells. J Pineal Res. 2008;45:318–27.
   PubMed Web of Science ®Google Scholar
• Peschke E, Frese T, Chankiewitz E, Peschke D, Preiss U, Schneyer U, . Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res. 2006;40:135–43.
   PubMed Web of Science ®Google Scholar
• Dubovsky SL, Warren C. Agomelatine, a melatonin agonist with antidepressant properties. Expert Opin Investig Drugs. 2009;18:1533–40.
   PubMed Web of Science ®Google Scholar